This is the authors' abstract. We don't add key points for this paper.
Introduction: The aim of this paper is to investigate the radiopacity of calcium hydroxide-based medications via means of contemporary image analyzing methods. Methods: Three commercial calcium hydroxide-based medications were used. Radiographic image data was obtained according to the International Organization for Standardization #6876(2012) specifications. Region of interest was determined for each specimen. Mean (±SD) grey values of the X-ray image data was measured with an image analyzing software. The calibration curve was created by curve-plotting software and the mean grey-values were matched versus Al values (mm Al). Data were analyzed with one-way ANOVA followed by Tukey’s multiple comparison test. Results: The radiopacity values of all medications are significantly different (p<0.05). The rank of the radiopacity values: TempCanal (4.94±0.31mmAl) > ProCalR (2.63±0.05mmAl) > Control (2.19±0.11mmAl). Discussion and Conclusion: There was a high difference in the radiopacity values of the radiopaque calcium hydroxide-based medicaments. Although the medicaments showed radiopacity of 2.19 to 4.94 mm aluminum equivalent, only TempCanal had values above the international standards as 3 mm aluminum equivalent.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Orhan et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: